Abstract
This study aimed to investigate what characterizes individuals with schizophrenia who experience more or less subjective executive dysfunction in everyday life compared to objective executive performance on neuropsychological tests.
Sixty-six participants with broad schizophrenia spectrum disorders completed a comprehensive assessment of executive function. Discrepancies between performance on neuropsychological tests (objective) and an extensive self-report questionnaire (subjective) of central executive functions (inhibition, shifting and working memory) were calculated. Higher level of self-efficacy was the best predictor of experiencing fewer subjective cognitive complaints compared to objective performance, followed by higher levels of disorganized symptoms. Depressive symptoms did not predict discrepancy between subjective and objective executive function. Higher estimated IQ predicted greater subjective working memory difficulties in everyday life despite better objective performance.
Results may aid clinicians in the assessment and remediation of cognitive impairment. Low self-efficacy may identify individuals who are not able to utilize their potential executive functions in daily life. Interventions aimed at fostering self-efficacy ought to be included in cognitive remediation for these individuals. Disorganized symptoms could prove useful in identifying individuals who are in need of cognitive remediation for executive dysfunction, despite that they overestimate their skills. These individuals may benefit from efforts to increase insight into cognitive dysfunction.
Keywords: Executive function, Subjective assessment, Cognition, Cognitive impairment, Schizophrenia, Psychosis, Self-efficacy
1. Introduction
Executive functions are among the most severely impaired cognitive functions in schizophrenia (East-Richard et al., 2020; Snyder et al., 2015). Deficits on both objective and subjective measures of executive functions such as inhibition, shifting and working memory have been reported (Bulzacka et al., 2013; Forbes et al., 2009; Garlinghouse et al., 2010; Laere et al., 2018; Westerhausen et al., 2011). Executive functions are also important predictors of functional outcome (Green, 1996; McGurk and Mueser, 2006), underlining the need for assessment of these functions.
Executive functions are challenging to assess because they are considered separate, but interacting cognitive functions (Friedman and Miyake, 2017). Neuropsychological tests may therefore lack the specificity needed to isolate components of executive functions (Snyder et al., 2015). On the other hand, executive functions are especially required during novel, complex situations. As a consequence neuropsychological tests may also fail to generalize to everyday situations because of their structured nature (Sbordone, 2014).
One way of addressing these challenges may be to combine tasks aimed at central components of executive functions with subjective assessment of real-world functioning in domains thought to reflect the same underlying components. However, diverging scores have been observed on objective (neuropsychological tests) and subjective measures (self-report questionnaires) across both healthy samples and clinical samples with neurological or psychiatric disorders (Toplak et al., 2013). One explanation for this is that despite measuring the same underlying constructs, objective measures are thought to capture skills, while subjective measures capture the application of these skills in the real-world context (Gioia et al., 2010; McAuley et al., 2010). Subjective measures on the other hand provide valuable information about everyday experience, but may be confounded by emotional states (Shwartz et al., 2020).
Research on the discrepancy between subjective and objective executive function in schizophrenia is limited, but studies on cognition in general have found the associations between subjective and objective measures to be weaker among individuals with schizophrenia than among healthy individuals (Medalia et al., 2008; Potvin et al., 2014). It has been suggested that co-morbid symptoms and lack of insight into cognitive impairment biases subjective cognitive assessment for a substantial portion of individuals with schizophrenia (Burton et al., 2016; Harvey and Pinkham, 2015; Raffard et al., 2020). Overestimation of cognition is problematic because it is associated with poorer functional outcomes (Gould et al., 2015). Similarly, overestimation of social cognition is related to poorer social function (Silberstein et al., 2018). Underestimation of skills is also problematic if lack of confidence leads to avoidance of activities (Silberstein and Harvey, 2019). Furthermore, subjective cognitive complaints are related to internalized stigma and poorer quality of life among persons with schizophrenia (Shin et al., 2016).
A novel method, the Stoicism-Sensitivity framework (Miskowiak et al., 2016) previously used in studies on bipolar and depressive disorders, may prove useful in quantifying the degree and direction of discrepancy between subjective and objective executive function. By comparing rankings on subjective and objective measures it is possible to view discrepancy as a bidirectional phenomenon ranging from stoicism (less subjective complaints relative to objective performance) to sensitivity (more subjective complaints relative to objective performance). Fig. 1 is an illustration of the framework where discrepancy scores fall along a scale ranging from −10 to +10.
Fig. 1.
The Stoicism-Sensitivity framework.
Since discrepancy between subjective and objective measures have been observed in many aspects of cognition and function in schizophrenia, the Stoicism-Sensitivity framework may offer a standardized way to study discrepancy. One advantage of the Stoicism-Sensitivity framework is that it quantifies both under- and overestimation along the same dimension. By using continuous values, the framework avoids having to establish cut-off points for distinct categories. Instead, participants are assigned individual scores for degree of stoicism or sensitivity relative to the sample. In addition, the framework avoids simply using high levels of subjective complaints as a proxy for accurate self-assessment.
Positive and negative symptoms are the most researched predictors of the discrepancy between subjective and objective cognition in schizophrenia, but results have been mixed (Homayoun et al., 2011; Potvin et al., 2014). New insight into the predictive value of psychotic symptoms could perhaps be gained by looking at a broader spectrum of psychotic symptoms. Wallwork et al.'s (2012) five factor consensus model of the Positive and Negative Syndrome Scale (PANSS) could prove optimal for this purpose. The model distinguishes between excited, disorganized and depressive symptoms in addition to positive and negative symptoms. Disorganized symptoms are particularly interesting in this regard as they share a stronger relationship with cognition than positive symptoms (Rodriguez-Jimenez et al., 2013; Ventura et al., 2010). Furthermore, depressive symptoms have been associated with more subjective cognitive complaints among persons with schizophrenia (Burton et al., 2016; Raffard et al., 2020; Sellwood et al., 2013).
Less attention has been paid to psychological mechanisms as predictors of the relationship between subjective and objective cognition (Cella et al., 2014). One such psychological mechanism that may have predictive value for the subjective-objective cognition discrepancy is self-efficacy. Self-efficacy is beliefs in one's capability of the behaviors needed to produce a desired outcome (Bandura, 1977). Higher self-efficacy increases motivation for, and effort in, the application of skills. People high in self-efficacy tend to set goals that are more ambitious, exert more effort and be more persistent in the face of difficulty. In contrast, people low in self-efficacy make fewer attempts and give up more easily (Bandura, 1977; Bandura, 2011). Self-efficacy is increasingly being recognized as an important factor in the relationship between cognition, negative symptoms and real-world functioning in schizophrenia (Allott et al., 2020; Ventura et al., 2014). Because of self-efficacy's relationship with motivation and effort, it has potential as an explanatory variable for the gap between objectively measured capacities and subjectively reported functioning.
The aim of the current study was to investigate potential predictors of the discrepancy between subjective and objective executive dysfunction, in persons with schizophrenia. Using the abovementioned Stoicism-Sensitivity framework, the degree and direction of the discrepancy between subjective and objective executive dysfunction was quantified (Miskowiak et al., 2016; Petersen et al., 2019). We used self-efficacy and a five-factor model of psychotic symptoms as predictors. Because experience with being integrated into society has shown to improve correlations between self-assessment and function in schizophrenia, outcomes were checked against age, current participation in school or work and level of education completed (Harvey and Pinkham, 2015; Olsson et al., 2019). Other potential confounds that have been seen to influence self-assessment in other contexts were also controlled for including gender, estimated general intellectual ability, diagnosis and overall symptoms (Harvey and Pinkham, 2015; Olsson et al., 2015). We hypothesized that:
-
•
Higher levels of self-efficacy predict lower subjective than objective dysfunction
-
•
More disorganized symptoms predict lower subjective than objective dysfunction
-
•
Greater depressive symptoms predict higher subjective than objective dysfunction
2. Methods
2.1. Participants
The sample (n = 66, 40 males and 26 females, aged 16–44 years, M = 25.53, SD = 6.56) consisted of individuals participating in a randomized controlled trial evaluating the effects of cognitive remediation targeting executive dysfunction (clinical.trials.gov: NCT03048695). The data presented are from the baseline assessment. Participants were recruited among patients referred for treatment of psychosis at Innlandet Hospital in Norway. The inclusion criteria were age 16 to 69 years, symptoms of broad schizophrenia spectrum disorder and self-reported executive dysfunction according to The Behavior Rating Inventory of Executive Function - Adult version, BRIEF-A (Roth and Gioia, 2005). In the Norwegian cultural context healthy participants score lower than U.S. norms, so a total score > T55 was considered clinically relevant (Løvstad et al., 2016). Exclusion criteria included comorbid neurological conditions, ongoing alcohol or substance abuse, intellectual impairment (IQ < 70) and treatment for psychosis for longer than five years. The study was approved by an ethics committee (The Regional Committee for Medical and Health Research Ethics of South-Eastern Norway, application no 2015/2118) and participants gave informed consent. See Table 1 for further description of participants.
Table 1.
Demographical and clinical characteristics (n = 66).
Participant characteristic | Frequency | Mean | SD | SE |
---|---|---|---|---|
Gender | ||||
Female | 26 (39.39%) | |||
Male | 40 (60.61%) | |||
Age | 25.53 | 6.55 | 0.81 | |
Age females | 25.38 | 5.99 | 1.17 | |
Age males | 25.62 | 6.96 | 1.10 | |
Education in years | 12.83 | 1.81 | 0.22 | |
Estimated IQa | 99.43 | 13.29 | 1.81 | |
Diagnosis (DSM-IV)b | ||||
Schizophrenia | 30 (45.50%) | |||
Schizoaffective disorder | 14 (21.20%) | |||
Schizophreniform disorder | 6 (9.10%) | |||
Psychotic disorder NOSc | 15 (22.7%) | |||
Delusional disorder | 1 (1.50%) | |||
Duration of untreated psychosis (weeks) | 219.38 | 209.77 | 25.82 | |
Hospitalizations | 3.28 | 5.07 | 0.63 | |
Months in hospital | 5.75 | 8.15 | 1.01 | |
Symptoms: Total scoresd | ||||
Psychosis – positive | 11.97 | 3.37 | 0.42 | |
Psychosis – negative | 15.43 | 4.87 | 0.61 | |
Psychosis – disorganized | 7.15 | 1.85 | 0.23 | |
Psychosis – depressive | 10.38 | 2.83 | 0.35 | |
Psychosis – excited | 8.62 | 2.56 | 0.32 | |
Summed | 53.55 | 8.91 | 1.11 | |
Positive, disorganized and excited | 27.74 | 6.00 | 0.74 | |
Depressive and negative | 25.82 | 5.99 | 0.74 | |
Symptoms: Mean scores | ||||
Psychosis – positive | 2.99 | 0.84 | 0.10 | |
Psychosis – negative | 2.57 | 0.81 | 0.10 | |
Psychosis – disorganized | 2.38 | 0.62 | 0.08 | |
Psychosis – depressive | 3.46 | 0.94 | 0.12 | |
Psychosis – excited | 2.15 | 0.64 | 0.08 | |
Drug therapy | 51 (77.30%) | |||
DDDe antipsychotics | 0.672 | 0.75 | 0.09 | |
DDD antidepressants | 0.491 | 0.87 | 0.11 | |
DDD mood stabilizers | 0.143 | 0.47 | 0.06 | |
DDD cnsf stimulants | 0.025 | 0.15 | 0.02 | |
DDD anxiolytics AHg | 0.015 | 0.09 | 0.01 | |
DDD anxiolytics BZh | 0.073 | 0.28 | 0.03 | |
DDD sedatives AH | 0.045 | 0.24 | 0.03 | |
DDD sedatives BZ | 0.131 | 0.38 | 0.05 |
IQ was estimated from two subtest of Wechsler Abbreviated Scale of Intelligence (WASI): Vocabulary and Matrix Reasoning. The normative mean of estimated IQ is 100 (SD = 15).
According to the criteria in the Diagnostic and statistical manual of mental disorders, DSM-IV-TR (American Psychiatric Association, 2000).
NOS = Not otherwise specified.
Summed scores for the items considered part of the five-factor consensus model (Wallwork et al., 2012). Scores on the Positive and Negative Syndrome Scale (PANSS) range from 1 “missing” to 7 “extreme,” 4 is considered psychotic threshold for delusions and hallucinations.
DDD = Defined daily dose.
cns = central nervous system.
AH = antihistamines.
BZ = benzodiazepines.
2.2. Procedure
Diagnostic assessment was conducted by a clinical psychologist according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR (American Psychiatric Association, 2000). Cognitive assessments and symptom ratings were undertaken by the same clinical psychologist or one of two trained psychiatric nurses. Training for the clinical assessment was provided by a specialist in psychiatry and for the cognitive assessment by a specialist in neuropsychology.
2.3. Objective cognitive measures
Inhibition was assessed using the age normed scaled score for time spent on Color-Word Interference Test condition three (Color-Word 3) from the DelisKaplan Executive Function System (D-KEFS) (Delis et al., 2001). The age normed T-score for commission errors from Conners Continuous Performance Test 3rd edition (CPT3) was converted to the same numerical scale as the other objective tests and combined with Color-Word 3 to make an inhibition domain score (Conners, 2014). Shifting was measured by averaging the scaled scores for time spent on condition four of the Color-Word Interference Test (Color-Word 4) and condition four of the Trail Making Test from D-KEFS (Delis et al., 2001). Working memory was assessed by averaging the age normed scaled scores from the Digit Span and Letter-Number Sequencing subtests in the Wechsler Adult Intelligence Scale – 4th edition, WAIS-IV (Wechsler, 2008). The domain scores were combined to create a mean score for objective executive function in concordance with current models of separate, but interacting executive components (Friedman and Miyake, 2017).
2.4. Subjective cognitive measures
Subjective executive function was measured with the 75-item questionnaire Behavior Rating Inventory of Executive Function - Adult version, BRIEF-A, (Roth and Gioia, 2005). The subscales Inhibit, Working Memory and Shift were selected because of their theorized conceptual overlap with the corresponding neuropsychological tests. The subscales had adequate Cronbach's Alpha scores showing good internal consistency: Inhibit (α .79), Shift (α .71) and Working Memory (α .71). The T-scores on the three subscales were averaged to create a total subjective executive functioning measure.
2.5. Predictor variables
Self-efficacy was assessed with the ten-item questionnaire General Perceived Self-Efficacy Scale (Schwarzer and Jerusalem, 1995). The scale's unidimensional factor structure, test-retest reliability and correlations with theoretically related concepts have been confirmed across cultures (Luszczynska et al., 2005; Scholz et al., 2002). High test-retest reliability and good internal consistency has also been found when employing the scale in schizophrenia (Chiu and Tsang, 2004). In the current study, the Cronbach α coefficient for the scale was α .85, indicating good internal consistency.
Symptoms of psychosis at the time of testing were assessed with the Structured Clinical Interview for the Positive and Negative Syndrome Scale for Schizophrenia, the SCI-PANSS (Kay et al., 1987). We grouped the symptoms according to a five-factor consensus model yielding a total score for positive, negative, disorganized, depressive and expressive symptoms (Wallwork et al., 2012). In the current study, the Cronbach alpha coefficients were α .65 for the positive symptoms subscale, α .86 for the negative symptoms subscale, α .59 for the disorganized symptoms subscale, α .54 for the depressive symptoms subscale and α .68 for the expressive symptoms subscale.
2.6. Variables controlled for
Significant predictors were checked against the effects of gender and general intellectual ability (IQ). IQ was estimated with Vocabulary and Matrix Reasoning from Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999). To assess the influence of amount of life-experience with challenging situations we used the variables age, years of education, education level completed (0 - not completed elementary school, 1 - completed elementary school, 2 - started secondary school, 3 - completed secondary school, 4 - started higher education, 5 - completed higher education) and occupational status. Occupational status was scored using the same criteria as the Social Functioning Scale (Birchwood et al., 1990): ranging from 10 for full-time work or study, via part-time and supported work placements to 0 if the participant had not worked in more than two years, was not actively job seeking and considered that working would be impossible. To check for the influence of remission status we entered summed symptoms on all five symptom groups from PANSS, as well as summed scores for positive, disorganized and excited symptoms and summed scores for depressive and negative symptoms (Wallwork et al., 2012). The other clinical variables controlled for were diagnosis, duration of untreated psychosis, number of hospitalizations, months spent in hospital and antipsychotic drug treatment.
2.7. Data analysis
We applied the Stoicism-Sensitivity framework previously used in studies on affective disorders (Miskowiak et al., 2016; Petersen et al., 2019). Assuming that accurate assessment would lead to a similar ranking on both measures, the objective rank was subtracted from the subjective rank in the inhibition, shifting and working memory domains, as well as for the combined total executive functioning score. The differences in ranking were then transformed into a stoicism-sensitivity score by using the following formula:
The scores fell along a scale ranging from −10 (maximum stoicism: least subjective complaints relative to objective performance) to 10 (maximum sensitivity: most subjective complaints relative to objective performance).
Multiple linear regression analysis was used to investigate predictors of sensitivity and stoicism. Analyses were performed using SPSS Statistics, version 26. Data were assumed to be missing at random and dealt with in a pairwise fashion. The Kolmogorov-Smirnov test was significant for disorganized symptoms D (65) = 0.149, p = .001, depressive symptoms D (65) = 0.147, p = .001 and self-efficacy D (56) = 0.152, p = .003, indicating deviation from the normal distribution of scores. Bias-corrected and accelerated bootstrapping was performed to ensure a robust analysis. Significant predictors were retained and separate linear regressions were run with each control variable to check for potential influence.
3. Results
3.1. Executive function
Mean total objective executive function score in the sample was significantly lower than the normative mean scaled score of 10 in a one-sample t-test: M 8.27, SD 2.16, SE 0.27, t (1, 64) = −6.439, p .000. Also, total subjective complaints, M 62.03, SD 9.23, SE 1.21, were significantly higher than the normative mean T-score of 50, t (1,57) = 9.93, p .000. See Table 2 for scores on measures of executive function and Table 3 for correlations between variables.
Table 2.
Scores on measures of executive function.
Variable | Mean | SD | SE | r | Sig. |
---|---|---|---|---|---|
Total objective executive functioninga | 8.37 | 2.06 | 0.26 | ||
Total subjective executive functioningb | 62.27 | 9.37 | 1.22 | −.10 | .480 |
Objective inhibition | |||||
Color-Word 3 inhibition | 7.76 | 3.35 | 0.42 | ||
CPT3 commissions | 57.15 | 10.91 | 1.35 | ||
Subjective inhibition | −.35 | .009 | |||
BRIEF-A inhibit subscale | 56.68 | 12.16 | 1.61 | ||
Objective shifting | 7.21 | 3.55 | 0.44 | ||
Trail making test 4 | 6.53 | 3.98 | 0.52 | ||
Color-Word 4 switching | 7.60 | 3.74 | 0.47 | ||
Subjective shifting | −.13 | .337 | |||
BRIEF-A shift subscale | 62.64 | 11.33 | 1.49 | ||
Objective working memory | 9.72 | 2.35 | 0.29 | ||
Digit span | 9.79 | 2.58 | 0.33 | ||
Letter-number sequencing | 9.69 | 2.75 | 0.35 | ||
Subjective working memory | −.05 | .724 | |||
BRIEF-A working memory subscale | 67.14 | 10.64 | 1.40 |
Note: Correlations are Pearson's correlations between objective and subjective domains. Bold values are significant at the p < .05 level in a two-tailed test. The only significant correlation detected was between greater subjective complaints of inhibition and lower scores on the tasks for objective inhibition, r − .35, p .009.
Objective scores derived from normed scaled scores in the D-KEFS and WAIS-IV all have a mean of 10 (SD = 3). Higher scores indicate better performance. CPT3 T-scores have a mean of 50 (SD = 10). CPT3 scores were converted to the same scale as the other objective scores before combining them.
Subjective scores are based on normed BRIEF-A T-scores with a mean of 50 (SD = 10). Higher scores indicate greater dysfunction.
Table 3.
Correlations between variables.
Subjective executive function |
Objective executive function |
Self-efficacy |
Symptoms of psychosis |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Inhibition | Shifting | Working memory | Total | Inhibition | Shifting | Working memory | Positive symptoms | Negative symptoms | Disorganized symptoms | Depressive symptoms | Excited symptoms | ||
Subjective EF | ||||||||||||||
Total | ||||||||||||||
Inhibition | .78⁎⁎ | |||||||||||||
Shifting | .80⁎⁎ | .32⁎⁎ | ||||||||||||
Working memory | .87⁎⁎ | .55⁎⁎ | .62⁎⁎ | |||||||||||
Objective EF | ||||||||||||||
Total | −.06 | −.18 | .08 | −.04 | ||||||||||
Inhibition | −.19 | −.31⁎ | −.01 | −.14 | .83⁎⁎ | |||||||||
Shifting | .05 | −.05 | .13 | .05 | .88⁎⁎ | .69⁎⁎ | ||||||||
Working memory | −.07 | −.14 | .03 | −.05 | .59⁎⁎ | .28⁎ | .22 | |||||||
Self-efficacy | −.41⁎⁎ | −.21 | −.47⁎⁎ | −.36⁎⁎ | −.33⁎ | −.14 | −.37⁎⁎ | −.16 | ||||||
Symptoms of psychosis | ||||||||||||||
Positive | −.13 | −.12 | −.08 | −.13 | .01 | −.03 | .03 | .02 | .15 | |||||
Negative | −.19 | −.28⁎ | −.05 | −.10 | −.03 | .01 | .01 | −.10 | −.03 | .10 | ||||
Disorganized | −.19 | −.23 | −.04 | −.17 | −.27⁎ | −.25⁎ | −.24 | −.13 | .24 | .38⁎⁎ | .16 | |||
Depressive | .17 | −.08 | .40⁎⁎ | .15 | .06 | .08 | .03 | .04 | −.20 | .10 | .14 | −.04 | ||
Excited | .14 | −.07 | .19 | .05 | .07 | −.13 | .12 | .14 | −.14 | .49⁎⁎ | −.07 | .17 | .12 | |
Estimated IQ | −.20 | −.30⁎ | −.13 | −.08 | .48⁎⁎ | .36⁎⁎ | .21 | .66⁎⁎ | .02 | −.19 | −.20 | −.22 | .00 | −.08 |
EF = Executive Function.
Correlation is significant at < p .05.
Correlation is significant at < p .01.
3.2. Stoicism and sensitivity
The distribution of stoicism and sensitivity scores for total executive function, M −1.19, SD 5.05, SE 0.67, showed a slight overrepresentation of stoicism. Thirty-two participants, 48.5%, ranked lower on total subjective complaints than objective measures (stoicism) and 26 participants, 39.4%, ranked higher on total subjective complaints than objective measures (sensitivity). Eight participants, 12.1%, had missing scores on at least one measure.
3.3. Predictors of stoicism and sensitivity
For total executive functioning, the strongest predictor of greater stoicism (fewer subjective complaints relative to objective performance) was higher self-efficacy, accounting for 27% of the variation, F (1, 51) = 19.21, p = .001, r2 = .27. See Table 4 for results of the regression analysis.
Table 4.
Linear model of predictors of stoicism and sensitivity in executive dysfunction with 95% bias corrected and accelerated confidence intervals reported in brackets. Confidence intervals and standard errors based on 1000 bootstrap samples.
Linear models | B | SE B | β | Sig. | r2 |
---|---|---|---|---|---|
Total executive function | |||||
Model 1 | .27 | ||||
Constant | 11.55 | 2.97 | |||
Self-efficacy | −0.52 [−0.73, −0.27] | 0.12 | −0.52 | .001 | |
Model 2 | .38 | ||||
Constant | 14.73 | 5.06 | |||
Self-efficacy | −0.46 [−0.70, −0.19] | 0.13 | −0.47 | .003 | |
Disorganized symptoms | −0.79 [−1.38, −0.16] | 0.31 | −0.29 | .013 | |
Depressive symptoms | 0.11 [−0.33, 0.50] | 0.21 | 0.06 | .598 | |
Positive symptoms | 0.10 [0.68, −0.34] | 0.24 | 0.07 | .679 | |
Negative symptoms | −0.14 [−0.39, −0.08] | 0.13 | −0.14 | .274 | |
Excited symptoms | 0.11 [−0.39, 0.59] | 0.24 | 0.06 | .642 | |
Inhibition | |||||
Model 1 | .08 | ||||
Constant | 6.19 | 2.78 | |||
Self-efficacy | −0.26 [−0.46, −0.03] | 0.11 | −0.28 | .019 | |
Model 2 | .29 | ||||
Constant | 16.29 | 5.21 | |||
Self-efficacy | −0.23 [−0.45, 0.01] | 0.12 | −0.24 | .057 | |
Disorganized symptoms | −1.07 [−1.78, −0.50] | 0.35 | −0.42 | .007 | |
Depressive symptoms | −0.07 [−0.56, 0.35] | 0.21 | −0.05 | .745 | |
Positive symptoms | 0.17 [−0.23, 0.64] | 0.22 | 0.13 | .429 | |
Negative symptoms | −0.16 [−0.38, 0.07] | 0.13 | −0.17 | .198 | |
Excited symptoms | −0.23 [−0.76, 0.45] | 0.26 | −0.13 | .351 | |
Shifting | |||||
Model 1 | .28 | ||||
Constant | 12.01 | 2.98 | |||
Self-efficacy | −0.53 [−0.73, −0.31] | 0.12 | −0.53 | .001 | |
Model 2 | .36 | ||||
Constant | 9.45 | 5.99 | |||
Self-efficacy | −0.45 [−0.68, −0.21] | 0.14 | −0.46 | .001 | |
Disorganized symptoms | −0.49 [−1.05, 0.05] | 0.28 | −0.19 | .086 | |
Depressive symptoms | 0.29 [−0.15, 0.65] | 0.23 | 0.17 | .188 | |
Positive symptoms | 0.07 [−0.37, 0.54] | 0.21 | 0.05 | .751 | |
Negative symptoms | −0.05 [−0.32, 0.21] | 0.14 | −0.05 | .717 | |
Excited symptoms | 0.14 [−0.37, 0.70] | 0.23 | 0.08 | .532 | |
Working memory | |||||
Model 1 | .17 | ||||
Constant | 8.46 | 2.74 | |||
Self-efficacy | −0.37 [−0.56, − 0.17] | 0.10 | −0.43 | .001 | |
Model 2 | .24 | ||||
Constant | 13.45 | 5.03 | |||
Self-efficacy | −0.33 [−0.57, −0.08] | 0.11 | −0.39 | .008 | |
Disorganized symptoms | −0.67 [−1.19, −0.08] | 0.29 | −0.29 | .028 | |
Depressive symptoms | −0.14 [−0.51, 0.25] | 0.20 | −0.10 | .485 | |
Positive symptoms | −0.02 [−0.40, 0.32] | 0.21 | −0.01 | .920 | |
Negative symptoms | −0.13 [−0.41, 0.16] | 0.12 | −0.16 | .252 | |
Excited symptoms | 0.33 [−0.10, 0.90] | 0.23 | 0.21 | .165 |
Note: Significant predictors have p-values in bold. Model 1 was considered the better fit as there was no significant F-change for model 2 for Total Executive function p .182, Shifting, p .438 and Working Memory, p .110. Model 2 was considered the better fit for Inhibition.
Separate analysis of the executive function domains found that greater self-efficacy was the strongest predictor of greater stoicism in shifting, Model 1: F (1, 50) = 19.85, p .000, r2 = .27, and working memory, F (1, 49) = 11.19, p .002, r2 = .19. However, in the inhibition domain more disorganized symptoms were a stronger predictor of stoicism than self-efficacy, Model 2: F (6, 44) = 3.01, p .015, Δr2 = .22. Depressive, positive and negative symptoms were not significant predictors of stoicism and sensitivity in any domain.
3.4. Controlling for demography and clinical variables
Gender did not change the significance of the predictive value of self-efficacy and disorganized symptoms on stoicism-sensitivity. Nor did experience from daily life measured by age, occupational status, years of education, level of education completed or estimated IQ. However, higher estimated IQ independently predicted greater sensitivity (greater subjective complaints despite better performance on tests) in the working memory domain only, F (3, 37) = 13.76, p .000, Δr2 = .15. The clinical variables, diagnosis, symptoms, duration of untreated psychosis and treatment had no significant bearing on the results. See Table 5 for details.
Table 5.
Influence of demographic and clinical variables.
Linear regression controlling for: | Total executive function |
Inhibition |
Shifting |
Working memory |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
F change | Sig. | Δr2 | F change | Sig. | Δr2 | F change | Sig | Δr2 | F change | Sig | Δr2 | |
Gender | 0.05 | .833 | .00 | 0.22 | .645 | .00 | 0.02 | .900 | .02 | 0.11 | .740 | .00 |
Age | 1.97 | .167 | .03 | 0.03 | .866 | .00 | 1.43 | .238 | .02 | 0.91 | .346 | .02 |
Estimated IQa | 1.44 | .237 | .02 | 0.79 | .379 | .01 | 0.42 | .521 | .00 | 12.03 | .001 | .15 |
Diagnosis | 0.52 | .476 | .01 | 0.07 | .796 | .00 | 0.24 | .628 | .00 | 0.00 | .972 | .00 |
DUPb | 1.66 | .204 | .02 | 1.91 | .173 | .03 | 1.15 | .290 | .02 | 0.21 | .652 | .00 |
Total symptoms | 0.02 | .894 | .00 | 0.79 | .378 | .01 | 1.09 | .302 | .02 | 0.22 | .642 | .00 |
Positive, disorganized & excited symptoms | 1.09 | .301 | .01 | 0.00 | .971 | .00 | 1.23 | .274 | .02 | 1.36 | .250 | .02 |
Negative and depressed symptoms | 0.48 | .492 | .01 | 1.39 | .245 | .02 | 0.19 | .994 | .00 | 2.71 | .106 | .04 |
Drug therapy (yes/no) | 0.43 | .513 | .01 | 0.40 | .533 | .01 | 0.76 | .388 | .01 | 0.35 | .556 | .01 |
DDDc antipsychotics | 0.00 | .991 | .00 | 0.86 | .357 | .02 | 0.09 | .761 | .00 | 0.08 | .775 | .00 |
Hospitalizations | 0.26 | .611 | .00 | 0.52 | .474 | .01 | 0.25 | .622 | .00 | 0.32 | .572 | .01 |
Months in hospital | 2.23 | .142 | .03 | 0.39 | .534 | .01 | 2.16 | .148 | .03 | 0.10 | .757 | .00 |
Occupational statusd | 0.35 | .558 | .01 | 0.08 | .778 | .00 | 0.18 | .676 | .00 | 0.49 | .487 | .01 |
Years of education | 0.15 | .705 | .00 | 0.54 | .465 | .01 | 0.13 | .717 | .00 | 0.39 | .538 | .01 |
Education completede | 0.06 | .807 | .00 | 1.20 | .280 | .02 | 0.15 | .705 | .00 | 0.37 | .546 | .01 |
Note: Significant predictors identified in the main analysis were retained (self-efficacy and disorganized symptoms) and controlling variables were added to the linear regression model one-by-one. Bootstrapping was performed (n = 1000) similar to main analysis. Values in bold are significant.
IQ was estimated from two subtest of Wechsler Abbreviated Scale of Intelligence (WASI): Vocabulary and Matrix Reasoning.
Duration of untreated psychosis.
DDD = Defined daily dose.
Occupational status was coded the same way as in the Social Functioning Scale (Birchwood et al., 1990).
Level of education completed was coded 0 - not completed elementary school, 1 - completed elementary school, 2 - started secondary school, 3 - completed secondary school, 4 - started higher education, 5 - completed higher education.
4. Discussion
The present study investigated potential predictors of discrepancy between subjective and objective executive function among persons with schizophrenia. The discrepancy was quantified using a novel framework creating a scale ranging from sensitivity (greater subjective complaints than objective dysfunction) to stoicism (fewer subjective complaints than objective dysfunction) (Miskowiak et al., 2016). We found that participants were characterized by both sensitivity and stoicism, which is in line with studies finding both over- and underestimation of cognition and social cognition (Burton et al., 2016; Silberstein et al., 2018). Stoicism and sensitivity scores were normally distributed, but there was slightly higher occurrence of stoicism in the sample in total executive function. This might seem surprising considering that subjective executive complaints were an inclusion criterion. However, this only shows that despite increased subjective complaints in the group as a whole compared to the normative mean in a healthy population, there are still individual variations in how well subjective complaints align with objective performance within the sample.
As expected, greater self-efficacy was associated with greater stoicism and lower self-efficacy was associated with greater sensitivity in all domains explaining a substantial amount of the variance in discrepancy in working memory, shifting and total executive function. This finding emphasizes the importance of exploring psychological factors as explanations for discrepancy between subjective and objective cognitive assessment (Cella et al., 2014). The effect of self-efficacy on stoicism-sensitivity was not better explained by gender, diagnosis, total symptoms, age, intellectual abilities, occupational status or having longer experience within the educational system. Nevertheless, we found that higher estimated IQ independent of self-efficacy, predicted greater sensitivity in the working memory domain alone. It is not clear whether this is due to an association between intellectual capacity and the ability to self-monitor working memory performance, or whether those who perform well on tasks measuring intellectual ability expect more from their working memory.
Our second hypothesis was partially supported. We expected higher levels of disorganized symptoms to predict greater stoicism, and found that it was the superior predictor of stoicism in the inhibition domain. The mechanism is not known, but perhaps disorganized symptoms interfere with attention so that subjective experiences of problems with inhibition to a greater degree go unnoticed. Disorganized symptoms appear to be fairly unexplored as a predictor of the subjective-objective cognition discrepancy, although one study found an association between a single item for disorientation and lower subjective cognitive complaints (Baliga et al., 2020).
Our third hypothesis was not supported. Higher levels of depressive symptoms did not predict greater sensitivity. Considering the consistent findings in other studies of a relationship between depressive symptoms and subjective cognitive complaints, it was surprising that depressive symptoms did not predict sensitivity in the current study (Burton et al., 2016; Durand et al., 2015; Raffard et al., 2020; Sellwood et al., 2013). One explanation for this might be that even though several participants had mild and moderate depressive symptoms, few had severe depressive symptoms. Studies with healthy individuals across cultures has shown that mild self-reported dysphoria is associated with more accurate self-assessment of capabilities - a phenomenon known as depressive realism. According to these studies, non-dysphoric individuals often overestimate their abilities (Moore and Fresco, 2012). Research on self-assessment of daily function in schizophrenia has also shown that depression was associated with accuracy rather than underestimation (Harvey et al., 2017). In addition, we used a clinician rating for depressive symptoms, whereas some of the previous studies have used self-reported depression scales which may have resulted in lower scores (Moore and Fresco, 2012).
Much of the emerging research on discrepancies between subjective and objective cognition in schizophrenia has favored lack of insight into cognitive impairment as the primary explanation (Medalia et al., 2008). We may also interpret the most extreme stoicism and sensitivity scores among our participants as over- and underestimation of executive skills. However, some degree of discrepancy between subjective and objective measures of executive function was expected, and may at least partially also be explained by the problems inherent in measuring executive function. Previous research has pointed out that task measures specific enough to isolate components of executive function in the lab often have little in common with the novel, complex real-life situations where the interplay of executive functions are most required (Sbordone, 2014). When combining objective and subjective measures we must keep in mind that we are measuring theoretically assumed underlying brain functions, but at two different levels of measurement. Executive tasks in the lab aim to tap capacity, while the subjective measures aim to tap performance in real-life (Gioia et al., 2010).
There are several possible interpretations of the finding that self-efficacy predicts stoicism and sensitivity. The direction of relationships between cognition, negative symptoms, real-world function and self-efficacy or related psychological concepts has proven difficult to disentangle and are currently under debate (Beck et al., 2018; Chang et al., 2017). It is possible that adequate self-efficacy is a pre-requisite for attempting activities that lead to greater stoicism when successful (Cardenas et al., 2013). However, it is also possible that self-efficacy is better preserved among individuals who make few attempts at challenging activities due to avoidant coping strategies (Lysaker et al., 2001). In addition, since self-efficacy is a subjective measure, it is not possible to rule out that challenges to accurate self-assessment also affect this measure for some participants.
4.1. Implications
Although the number of studies exploring subjective cognition in schizophrenia is growing, there are few specifically focusing on executive functions, making conclusions tentative at this point. Still, the present study has several possible implications. The results indicate that disorganized symptoms can help identify stoic individuals. Stoic individuals may be more likely to turn down cognitive remediation (Balzan et al., 2014). When daily function indicates that stoic individuals may benefit from cognitive remediation or supportive services, interventions should include efforts to increase recognition of cognitive difficulties in everyday life (Medalia et al., 2008).
However, our results also raise ethical concerns over whether interventions aimed at increasing insight into cognitive impairment may harm self-efficacy (Cella et al., 2014; Rose et al., 2008). This could be counterproductive, considering the importance of self-efficacy to wellbeing in severe mental illness (Gleeson et al., 2020; Hansson, 2006). Sensitive participants may also have difficulty engaging during cognitive remediation due to low self-efficacy (Beck et al., 2018; Chang et al., 2017). To ensure that interventions are effective and ethically sound for sensitive individuals, they should be carried out in a manner that fosters self-efficacy (Allott et al., 2020; Cella and Wykes, 2019).
4.2. Strengths and limitations
The extensive test battery and questionnaire specifically tapping core components of executive function is a strength of this study. There are, however, also some limitations that warrant mentioning. Our selection of objective measures allow for comparison with previous research, although the specificity of these measures has been drawn into question (Barch et al., 2009; Miyake et al., 2000). We chose to focus on components of executive functions that aligned with the subscales of the BRIEF-A questionnaire. Tasks that are more complex may be subject to task impurity (Donohoe and Robertson, 2003; Roca et al., 2014). However, we acknowledge that the inclusion of more complex executive tasks such Wisconsin Card Sorting Test which has been shown to predict function (McGurk and Meltzer, 2000) may have been beneficial. Subjective executive complaints were part of the inclusion criteria, but we assume our sample to be representative of persons with schizophrenia in this regard since scores were similar to other studies (Bulzacka et al., 2013; Garlinghouse et al., 2010).
Importantly, the analyses were correlational and thus cannot establish causal relationships between the variables. Because the study is part of a cognitive remediation trial, we did not include a healthy control group and scores were instead standardized using norms. Precautions should be taken in the generalization of findings because the sample in the study is somewhat heterogeneous and small. Specifically, the sample has a young mean age and excluded anyone who had received treatment for longer than five years. Therefore, we do not know if the results will generalize to individuals who have been living with schizophrenia spectrum disorders for longer. A longer duration in stable remission from psychotic symptoms is related to higher correlations between self-assessment and daily function (Harvey et al., 2019; Olsson et al., 2015). For the youngest participants in the present study variables such as level of education and occupational status are likely to change since some are currently still in secondary school.
Not all potential predictors of discrepancy were accounted for. For example, the present study could have benefitted from the inclusion of more proximal measures of functioning in daily life. Experience with everyday situations has previously shown to be associated with more accurate assessment in other areas (Harvey and Pinkham, 2015). This could be interesting directions for future research, in addition to longitudinal studies of discrepancy over time.
CRediT authorship contribution statement
Ingvild Haugen: Investigation, formal analysis and writing – original draft, Jan Stubberud: Conceptualization, Supervision and writing – review and editing, Torill Ueland: Writing – review and editing, Elisabeth Haug: Conceptualization, supervision and writing – review and editing, Merete Glenne Øie: Conceptualization, funding acquisition, project administration, supervision and writing – review and editing.
Declaration of competing interest
The authors have no conflicting interests to declare.
Acknowledgements
The study was funded by the South-Eastern Norway Health Authority (grant number 2017012), Innlandet Hospital Trust (grant number 150602) and University of Oslo (grant number 353139). Sponsors had no involvement in the execution of the study.
References
- Allott K., Steele P., Boyer F. Cognitive strengths-based assessment and intervention in first-episode psychosis: a complementary approach to addressing functional recovery? Clin. Psychol. Rev. 2020;79 doi: 10.1016/j.cpr.2020.101871. [DOI] [PubMed] [Google Scholar]
- American Psychiatric Association . 4th ed. American Psychiatric Association; Washington, DC: 2000. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. [Google Scholar]
- Baliga S.P., Kamath R.M., Kedare J.S. Subjective cognitive complaints and its relation to objective cognitive performance, clinical profile, clinical insight, and social functioning in patients of schizophrenia: a cross-sectional study. Indian J. Psychiatry. 2020;62(2):178–185. doi: 10.4103/psychiatry.IndianJPsychiatry_639_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Balzan R.P., Neaves A., Denson L.A., Liu D., Galletly C. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between? Cogn. Neuropsychiatry. 2014;19(6):471–484. doi: 10.1080/13546805.2014.909311. [DOI] [PubMed] [Google Scholar]
- Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol. Rev. 1977;84(2):191–215. doi: 10.1037//0033-295X.84.2.191. [DOI] [PubMed] [Google Scholar]
- Bandura A. On the functional properties of perceived self-efficacy revisited. J. Manag. 2011;38(1):9–44. doi: 10.1177/0149206311410606. [DOI] [Google Scholar]
- Barch D.M., Braver T.S., Carter C.S., Poldrack R.A., Robbins T.W. CNTRICS final task selection: executive control. Schizophr. Bull. 2009;35(1):115–135. doi: 10.1093/schbul/sbn154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beck A.T., Himelstein R., Bredemeier K., Silverstein S.M., Grant P. What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors. Psychol. Med. 2018;48(16):2776–2785. doi: 10.1017/S0033291718000442. [DOI] [PubMed] [Google Scholar]
- Birchwood M., Smith J., Cochrane R., Wetton S., Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br. J. Psychiatry. 1990;157(12):853–859. doi: 10.1192/bjp.157.6.853. [DOI] [PubMed] [Google Scholar]
- Bulzacka E., Vilain J., Schurhoff F., Meary A., Leboyer M., Szoke A. A self-administered executive functions ecological questionnaire (the behavior rating inventory of executive function - adult version) shows impaired scores in a sample of patients with schizophrenia. Ment. Illn. 2013;5(1):e4. doi: 10.4081/mi.2013.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burton C.Z., Harvey P.D., Patterson T.L., Twamley E.W. Neurocognitive insight and objective cognitive functioning in schizophrenia. Schizophr. Res. 2016;171(1–3):131–136. doi: 10.1016/j.schres.2016.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cardenas V., Abel S., Bowie C.R. When functional capacity and real-world functioning converge: the role of self-efficacy. Schizophr. Bull. 2013;39(4):908–916. doi: 10.1093/schbul/sbs004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cella M., Wykes T. The nuts and bolts of Cognitive Remediation: exploring how different training components relate to cognitive and functional gains. Schizophr. Res. 2019;203:12–16. doi: 10.1016/j.schres.2017.09.012. [DOI] [PubMed] [Google Scholar]
- Cella M., Swan S., Medin E., Reeder C., Wykes T. Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem. Psychol. Med. 2014;44(3):469–476. doi: 10.1017/S0033291713001189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang W.C., Kwong V.W., Hui C.L., Chan S.K., Lee E.H., Chen E.Y. Relationship of amotivation to neurocognition, self-efficacy and functioning in first-episode psychosis: a structural equation modeling approach. Psychol. Med. 2017;47(4):755–765. doi: 10.1017/S0033291716003044. [DOI] [PubMed] [Google Scholar]
- Chiu F.P.F., Tsang H.W.H. Validation of the Chinese general self-efficacy scale among individuals with schizophrenia in Hong Kong. Int. J. Rehabil. Res. 2004;27(2):159–161. doi: 10.1097/01.mrr.0000127640.55118.6b. [DOI] [PubMed] [Google Scholar]
- Conners K.C. 3rd edn. Multi-Health Systems Inc; Toronto: 2014. Conners Continuous Performance Test. [Google Scholar]
- Delis D.C., Kaplan E., Kramer J.H. NCS Pearson, Inc; Bloomington: 2001. Delis–Kaplan Executive Function System. [Google Scholar]
- Donohoe G., Robertson I.H. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review. Neurocase. 2003;9(2):97–108. doi: 10.1076/neur.9.2.97.15075. [DOI] [PubMed] [Google Scholar]
- Durand D., Strassnig M., Sabbag S. Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies. Eur. Neuropsychopharmacol. 2015;25(2):185–191. doi: 10.1016/j.euroneuro.2014.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- East-Richard C., R. -Mercier A., Nadeau D., Cellard C. Transdiagnostic neurocognitive deficits in psychiatry: a review of meta-analyses. Can. Psychol. 2020;61(3):190–214. doi: 10.1037/cap0000196. [DOI] [Google Scholar]
- Forbes N.F., Carrick L.A., McIntosh A.M., Lawrie S.M. Working memory in schizophrenia: a meta-analysis. Psychol. Med. 2009;39(6):889–905. doi: 10.1017/S0033291708004558. [DOI] [PubMed] [Google Scholar]
- Friedman N.P., Miyake A. Unity and diversity of executive functions: individual differences as a window on cognitive structure. Cortex. 2017;86:186–204. doi: 10.1016/j.cortex.2016.04.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garlinghouse M.A., Roth R.M., Isquith P.K., Flashman L.A., Saykin A.J. Subjective rating of working memory is associated with frontal lobe volume in schizophrenia. Schizophr. Res. 2010;120(1–3):71–75. doi: 10.1016/j.schres.2010.02.1067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gioia G.A., Kenworthy L., Isquith P.K. Executive function in the real world: BRIEF lessons from Mark Ylvisaker. J. Head Trauma Rehabil. 2010;25(6):433–439. doi: 10.1097/HTR.0b013e3181fbc272. [DOI] [PubMed] [Google Scholar]
- Gleeson J.F.M., Eleftheriadis D., Santesteban-Echarri O. Positive and meaningful lives: systematic review and meta-analysis of eudaimonic well-being in first-episode psychosis. Early Interv. Psychiatry. 2020 doi: 10.1111/eip.13049. [DOI] [PubMed] [Google Scholar]
- Gould F., McGuire L.S., Durand D. Self-assessment in schizophrenia: accuracy of evaluation of cognition and everyday functioning. Neuropsychology. 2015;29(5):675–682. doi: 10.1037/neu0000175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry. 1996;153(3):321–330. doi: 10.1176/ajp.153.3.321. [DOI] [PubMed] [Google Scholar]
- Hansson L. Determinants of quality of life in people with severe mental illness. Acta Psychiatr. Scand. 2006;(429):46–50. doi: 10.1111/j.1600-0447.2005.00717.x. [DOI] [PubMed] [Google Scholar]
- Harvey P.D., Pinkham A. Impaired self-assessment in schizophrenia: why patients misjudge their cognition and functioning. Curr. Psychiatr. Ther. 2015;14(4):53–59. https://www.mdedge.com/psychiatry/article/98117/schizophrenia-other-psychotic-disorders/impaired-self-assessment?sso=true Available at: [Google Scholar]
- Harvey P.D., Twamley E.W., Pinkham A.E., Depp C.A., Patterson T.L. Depression in schizophrenia: associations with cognition, functional capacity, everyday functioning, and self-assessment. Schizophr. Bull. 2017;43(3):575–582. doi: 10.1093/schbul/sbw103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harvey P.D., Strassnig M.T., Silberstein J. Prediction of disability in schizophrenia: symptoms, cognition, and self-assessment. J. Exp. Psychopathol. 2019;10(3) doi: 10.1177/2043808719865693. (pp. 204380871986569) [DOI] [Google Scholar]
- Homayoun S., Nadeau-Marcotte F., Luck D., Stip E. Subjective and objective cognitive dysfunction in schizophrenia - is there a link? Front. Psychol. 2011;2:148. doi: 10.3389/fpsyg.2011.00148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261. [DOI] [PubMed] [Google Scholar]
- Laere E., Tee S.F., Tang P.Y. Assessment of cognition in schizophrenia using trail making test: a meta-analysis. Psychiatry Investig. 2018;15(10):945–955. doi: 10.30773/pi.2018.07.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Løvstad M., Sigurdardottir S., Andersson S. Behavior rating inventory of executive function adult version in patients with neurological and neuropsychiatric conditions: symptom levels and relationship to emotional distress. J. Int. Neuropsychol. Soc. 2016;22(6):682–694. doi: 10.1017/S135561771600031X. [DOI] [PubMed] [Google Scholar]
- Luszczynska A., Scholz U., Schwarzer R. The general self-efficacy scale: multicultural validation studies. J. Psychol. 2005;139(5):439–457. doi: 10.3200/JRLP.139.5.439-457. [DOI] [PubMed] [Google Scholar]
- Lysaker P.H., Clements C.A., Wright D.E., Evans J., Marks K.A. Neurocognitive correlates of helplessness, hopelessness, and well-being in schizophrenia. J. Nerv. Ment. Dis. 2001;189(7):457–462. doi: 10.1097/00005053-200107000-00007. [DOI] [PubMed] [Google Scholar]
- McAuley T., Chen S., Goos L., Schachar R., Crosbie J. Is the behavior rating inventory of executive function more strongly associated with measures of impairment or executive function? J. Int. Neuropsychol. Soc. 2010;16(3):495–505. doi: 10.1017/S1355617710000093. [DOI] [PubMed] [Google Scholar]
- McGurk S.R., Meltzer H.Y. The role of cognition in vocational functioning in schizophrenia. Schizophr. Res. 2000;45(3):175–184. doi: 10.1016/S0920-9964(99)00198-X. [DOI] [PubMed] [Google Scholar]
- McGurk S.R., Mueser K.T. Cognitive and clinical predictors of work outcomes in clients with schizophrenia receiving supported employment services: 4-year follow-up. Adm. Policy Ment. Health Ment. Health Serv. Res. 2006;33(5):598–606. doi: 10.1007/s10488-006-0070-2. [DOI] [PubMed] [Google Scholar]
- Medalia A., Thysen J., Freilich B. Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure? Schizophr. Res. 2008;105(1–3):156–164. doi: 10.1016/j.schres.2008.07.007. [DOI] [PubMed] [Google Scholar]
- Miskowiak K.W., Petersen J.Z., Ott C.V. Predictors of the discrepancy between objective and subjective cognition in bipolar disorder: a novel methodology. Acta Psychiatr. Scand. 2016;134(6):511–521. doi: 10.1111/acps.12649. [DOI] [PubMed] [Google Scholar]
- Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex “Frontal Lobe” tasks: a latent variable analysis. Cogn. Psychol. 2000;41(1):49–100. doi: 10.1006/cogp.1999.0734. [DOI] [PubMed] [Google Scholar]
- Moore M.T., Fresco D.M. Depressive realism: a meta-analytic review. Clin. Psychol. Rev. 2012;32(6):496–509. doi: 10.1016/j.cpr.2012.05.004. [DOI] [PubMed] [Google Scholar]
- Olsson M., Carlström E., Marklund B., Helldin L., Hjärthag F. Assessment of distress and quality of life: a comparison of self-assessments by outpatients with a schizopsychotic illness and the clinical judgment of nurses. Arch. Psychiatr. Nurs. 2015;29(5):284–289. doi: 10.1016/j.apnu.2015.05.001. [DOI] [PubMed] [Google Scholar]
- Olsson A.-K., Hjärthag F., Helldin L. Overestimated function in patients with schizophrenia: a possible risk factor for inadequate support? Schizophr. Res. 2019;206:194–199. doi: 10.1016/j.schres.2018.11.027. [DOI] [PubMed] [Google Scholar]
- Petersen J.Z., Porter R.J., Miskowiak K.W. Clinical characteristics associated with the discrepancy between subjective and objective cognitive impairment in depression. J. Affect. Disord. 2019;246:763–774. doi: 10.1016/j.jad.2018.12.105. [DOI] [PubMed] [Google Scholar]
- Potvin S., Pelletier J., Stip E. Neurocognitive insight in schizophrenia: a meta-analysis. Sante Ment. Que. 2014;39(2):183. doi: 10.7202/1027839ar. [DOI] [PubMed] [Google Scholar]
- Raffard S., Lebrun C., Bayard S., Macgregor A., Capdevielle D. Self-awareness deficits of cognitive impairment in individuals with schizophrenia. Really? Front. Psych. 2020;11:731. doi: 10.3389/fpsyt.2020.00731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roca M., Manes F., Cetkovich M. The relationship between executive functions and fluid intelligence in schizophrenia. Front. Behav. Neurosci. 2014;8:46. doi: 10.3389/fnbeh.2014.00046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodriguez-Jimenez R., Bagney A., Mezquita L. Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia. Schizophr. Res. 2013;143(1):77–83. doi: 10.1016/j.schres.2012.10.020. [DOI] [PubMed] [Google Scholar]
- Rose D., Farrier D., Doran A.-M., Sporle T., Bogner D. What do clients think of cognitive remediation therapy? A consumer-led investigation of satisfaction and side-effects. Am. J. Psychiatr. Rehabil. 2008;11(2):181–204. doi: 10.1080/15487760801963694. [DOI] [Google Scholar]
- Roth R.M., Gioia G.A. Psychological Assessment Resources; Lutz, Florida: 2005. Behavior Rating Inventory of Executive Function - Adult Version. [Google Scholar]
- Sbordone R.J. The hazards of strict reliance on neuropsychological tests. Appl. Neuropsychol. Adult. 2014;21(2):98–107. doi: 10.1080/09084282.2012.762630. [DOI] [PubMed] [Google Scholar]
- Scholz U., Gutiérrez Doña B., Sud S., Schwarzer R. Is general self-efficacy a universal construct? Psychometric findings from 25 countries. Eur. J. Psychol. Assess. 2002;18(3):242–251. doi: 10.1027//1015-5759.18.3.242. [DOI] [Google Scholar]
- Schwarzer R., Jerusalem M. Generalized self-efficacy scale. In: Weinman J., Wright S., Johnston M., editors. Measures in Health Psychology: A User’s Portfolio. NFER-NELSON; Windsor, England: 1995. pp. 35–37. [Google Scholar]
- Sellwood W., Morrison A.P., Beck R., Heffernan S., Law H., Bentall R.P. Subjective cognitive complaints in schizophrenia: relation to antipsychotic medication dose, actual cognitive performance, insight and symptoms. PLoS One. 2013;8(12):e83774. doi: 10.1371/journal.pone.0083774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shin Y.J., Joo Y.H., Kim J.H. Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia. Neuropsychiatr. Dis. Treat. 2016;12:1411–1417. doi: 10.2147/NDT.S108537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shwartz S.K., Roper B.L., Arentsen T.J., Crouse E.M., Adler M.C. The Behavior Rating Inventory of Executive Function®-Adult Version is related to emotional distress, not executive dysfunction, in a veteran sample. Arch. Clin. Neuropsychol. 2020;35(6):701–716. doi: 10.1093/arclin/acaa024. [DOI] [PubMed] [Google Scholar]
- Silberstein J., Harvey P.D. Cognition, social cognition, and self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes. CNS Spectr. 2019;24(1):88–93. doi: 10.1017/S1092852918001414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silberstein J.M., Pinkham A.E., Penn D.L., Harvey P.D. Self-assessment of social cognitive ability in schizophrenia: association with social cognitive test performance, informant assessments of social cognitive ability, and everyday outcomes. Schizophr. Res. 2018;199:75–82. doi: 10.1016/j.schres.2018.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Snyder H.R., Miyake A., Hankin B.L. Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches. Front. Psychol. 2015;6:328. doi: 10.3389/fpsyg.2015.00328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toplak M.E., West R.F., Stanovich K.E. Practitioner review: do performance-based measures and ratings of executive function assess the same construct? J. Child Psychol. Psychiatry. 2013;54(2):131–143. doi: 10.1111/jcpp.12001. [DOI] [PubMed] [Google Scholar]
- Ventura J., Thames A.D., Wood R.C., Guzik L.H., Hellemann G.S. Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits. Schizophr. Res. 2010;121(1–3):1–14. doi: 10.1016/j.schres.2010.05.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ventura J., Subotnik K.L., Ered A. The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia. Schizophr. Bull. 2014;40(6):1308–1318. doi: 10.1093/schbul/sbu002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallwork R.S., Fortgang R., Hashimoto R., Weinberger D.R., Dickinson D. Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr. Res. 2012;137(1–3):246–250. doi: 10.1016/j.schres.2012.01.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wechsler D. NCS Pearson, Inc; San Antonio, Texas: 1999. Wechsler Abbreviated Scale of Intelligence (WASI) [Google Scholar]
- Wechsler D. Pearson Assessment; San Antonio, Texas: 2008. Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) [Google Scholar]
- Westerhausen R., Kompus K., Hugdahl K. Impaired cognitive inhibition in schizophrenia: a meta-analysis of the Stroop interference effect. Schizophr. Res. 2011;133(1–3):172–181. doi: 10.1016/j.schres.2011.08.025. [DOI] [PubMed] [Google Scholar]